Quintiles GmbH Backs Drug Discovery Transformation with Major Donation to Sage Bionetworks

SEATTLE--(BUSINESS WIRE)--Sage Bionetworks, a not-for-profit organization established to develop an open-access genomic platform for use in drug discovery, announced a major founding donation today from Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide.

MORE ON THIS TOPIC